These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents. Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068 [TBL] [Abstract][Full Text] [Related]
6. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis. Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361 [TBL] [Abstract][Full Text] [Related]
7. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
8. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes. Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706 [TBL] [Abstract][Full Text] [Related]
9. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of cytotoxicity by combining pyrenyl-dendrimers and arene ruthenium metallacages. Pitto-Barry A; Zava O; Dyson PJ; Deschenaux R; Therrien B Inorg Chem; 2012 Jul; 51(13):7119-24. PubMed ID: 22716166 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes. Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028 [TBL] [Abstract][Full Text] [Related]
13. Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis. Zheng W; Luo Q; Lin Y; Zhao Y; Wang X; Du Z; Hao X; Yu Y; Lü S; Ji L; Li X; Yang L; Wang F Chem Commun (Camb); 2013 Nov; 49(87):10224-6. PubMed ID: 23856988 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents. Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889 [TBL] [Abstract][Full Text] [Related]
15. Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug development. Babak MV; Meier SM; Legin AA; Adib Razavi MS; Roller A; Jakupec MA; Keppler BK; Hartinger CG Chemistry; 2013 Mar; 19(13):4308-18. PubMed ID: 23341078 [TBL] [Abstract][Full Text] [Related]
16. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage. Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276 [TBL] [Abstract][Full Text] [Related]
17. Lipid based nanovectors containing ruthenium complexes: a potential route in cancer therapy. Vaccaro M; Del Litto R; Mangiapia G; Carnerup AM; D'Errico G; Ruffo F; Paduano L Chem Commun (Camb); 2009 Mar; (11):1404-6. PubMed ID: 19259602 [TBL] [Abstract][Full Text] [Related]
18. Dinuclear ruthenium(II) triple-stranded helicates: luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines. Pascu GI; Hotze AC; Sanchez-Cano C; Kariuki BM; Hannon MJ Angew Chem Int Ed Engl; 2007; 46(23):4374-8. PubMed ID: 17477461 [No Abstract] [Full Text] [Related]
19. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents. Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536 [TBL] [Abstract][Full Text] [Related]
20. Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π. Lin Y; Huang Y; Zheng W; Wang F; Habtemariam A; Luo Q; Li X; Wu K; Sadler PJ; Xiong S J Inorg Biochem; 2013 Nov; 128():77-84. PubMed ID: 23942162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]